Robotic vs. Laparoscopic Cholecystectomy: What Our New Multihospital Study Reveals At PittSurgery, we're always asking the same question before every operation: what's actually best for this patient? A new study led by @AmerZureikatMD  analyzing 1,828 patients across 8 hospitals (2020–2021), offers some of the clearest evidence yet on when robotic surgery adds real value in gallbladder removal — and when it doesn't. Key findings: -Robotic cholecystectomy (RC) showed lower rates of adverse outcomes overall (3.3% vs. 8.7% for laparoscopic) and shorter hospital stays. -The advantage was concentrated in high-risk cases (Nassar score ≥7) and patients with elevated BMI — in these groups, laparoscopic surgery carried significantly higher odds of complications or conversion to open surgery.  -For low/intermediate-risk patients with lower BMI, both approaches performed comparably.  -The catch: RC cost roughly $2,200–$2,400 more per case than LC, regardless of risk level.  Dr. Zureikat's team also validated a preoperative risk calculator (AUC ~0.74–0.75) to help surgeons match the right approach to the right patient. Robotic surgery isn't universally "better" — its clinical edge shows up specifically in technically complex or higher-risk cases. For most routine cholecystectomies, laparoscopic surgery remains equally safe and far more cost-effective. Smarter patient selection — not blanket adoption of new technology — may be the real path to better outcomes and resource stewardship. What's your take: should risk-stratified guidelines like this shape hospital purchasing and OR scheduling decisions? JAMA Surgery: Published today Published Online: September 16, 2026. doi:10.1001/jamasurg.2026.4128 #PittSurgery #JAMASurgery #RoboticSurgery#LaparoscopicSurgery #Cholecystectomy#SurgicalInnovation #PatientSafety#ClinicalResearch #EvidenceBasedMedicine#SurgicalOutcomes